The risk of dying from cancer has steadily declined, sparing some 4 million lives in the United States. This downward trend can partially be explained by early cancer detection and treatment advancements. However, there are many exciting advancements in cancer research utilizing new technologies, gene therapies and artificial intelligence. Joining Bob in a conversation on the state of cancer research is Dr. Bill Fintel, Medical Director of Carilion Clinic for Oncology and faculty member at the Virginia Tech Carillion School of Medicine.